181 related articles for article (PubMed ID: 22668957)
1. The characteristics of juvenile myasthenia gravis among South Africans.
Heckmann JM; Hansen P; Van Toorn R; Lubbe E; Janse van Rensburg E; Wilmshurst JM
S Afr Med J; 2012 May; 102(6):532-6. PubMed ID: 22668957
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of patients with Myasthenia gravis from the Henan province, China.
Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
[TBL] [Abstract][Full Text] [Related]
3. Treatment outcome in juvenile-onset myasthenia gravis.
Jastrzębska A; Jastrzębski M; Ryniewicz B; Kostera-Pruszczyk A
Muscle Nerve; 2019 May; 59(5):549-554. PubMed ID: 30734335
[TBL] [Abstract][Full Text] [Related]
4. Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis.
Clifford KM; Hobson-Webb LD; Benatar M; Burns TM; Barnett C; Silvestri NJ; Howard JF; Visser A; Crum BA; Nowak R; Beekman R; Kumar A; Ruzhansky K; Chen IA; Pulley MT; Laboy SM; Fellman MA; Howard DB; Kolb NA; Greene SM; Pasnoor M; Dimachkie MM; Barohn RJ; Hehir MK
Muscle Nerve; 2019 Apr; 59(4):404-410. PubMed ID: 30575980
[TBL] [Abstract][Full Text] [Related]
5. Juvenile myasthenia gravis with prepubertal onset.
Evoli A; Batocchi AP; Bartoccioni E; Lino MM; Minisci C; Tonali P
Neuromuscul Disord; 1998 Dec; 8(8):561-7. PubMed ID: 10093062
[TBL] [Abstract][Full Text] [Related]
6. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy.
Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H
Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058
[TBL] [Abstract][Full Text] [Related]
7. Clinical Features, Treatment, and Prognostic Factors of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort.
Bi Z; Ge H; Zhang Q; Gao H; Yang M; Zhan J; Lin J; Gui M; Li Y; Ji S; Cao Y; Bu B
Pediatr Neurol; 2023 Sep; 146():31-39. PubMed ID: 37421800
[TBL] [Abstract][Full Text] [Related]
8. Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients.
Lindner A; Schalke B; Toyka KV
J Neurol; 1997 Aug; 244(8):515-20. PubMed ID: 9309559
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis in South Africans: racial differences in clinical manifestations.
Heckmann JM; Owen EP; Little F
Neuromuscul Disord; 2007 Dec; 17(11-12):929-34. PubMed ID: 17720497
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.
Wong V; Hawkins BR; Yu YL
Acta Neurol Scand; 1992 Jul; 86(1):68-72. PubMed ID: 1519477
[TBL] [Abstract][Full Text] [Related]
11. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
[TBL] [Abstract][Full Text] [Related]
12. Correlation of anti-acetylcholine receptor antibody levels and long-term outcomes of juvenile myasthenia gravis in Taiwan: a case control study.
Chou CC; Su IC; Chou IJ; Lin JJ; Lan SY; Wang YS; Kong SS; Chen YJ; Hsieh MY; Hung PC; Wang HS; Chou ML; Lin KL;
BMC Neurol; 2019 Jul; 19(1):170. PubMed ID: 31319795
[TBL] [Abstract][Full Text] [Related]
13. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
15. Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status.
Usmani A; Kwan L; Wahib-Khalil D; Trivedi J; Nations S; Sarode R
J Clin Apher; 2019 Aug; 34(4):416-422. PubMed ID: 30779438
[TBL] [Abstract][Full Text] [Related]
16. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
Kupersmith MJ; Latkany R; Homel P
Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
[TBL] [Abstract][Full Text] [Related]
17. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BRF; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Verschuuren JJGM; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Silvestri NJ; Conwit R; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
Lancet Neurol; 2019 Mar; 18(3):259-268. PubMed ID: 30692052
[TBL] [Abstract][Full Text] [Related]
18. Outcome after Robotic-Assisted Thymectomy in Children and Adolescents with Acetylcholine Receptor Antibody-Positive Juvenile Myasthenia Gravis.
Della Marina A; Kölbel H; Müllers M; Kaiser O; Ismail M; Swierzy M; Rueckert JC; Schara U
Neuropediatrics; 2017 Aug; 48(4):315-322. PubMed ID: 28628938
[No Abstract] [Full Text] [Related]
19. Juvenile myasthenia gravis: a twenty-year experience.
Castro D; Derisavifard S; Anderson M; Greene M; Iannaccone S
J Clin Neuromuscul Dis; 2013 Mar; 14(3):95-102. PubMed ID: 23492460
[TBL] [Abstract][Full Text] [Related]
20. Juvenile myasthenia gravis in Norway: Clinical characteristics, treatment, and long-term outcome in a nationwide population-based cohort.
Popperud TH; Boldingh MI; Rasmussen M; Kerty E
Eur J Paediatr Neurol; 2017 Sep; 21(5):707-714. PubMed ID: 28457757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
